Nectin-4 targeting antibody drug conjugate 1 (Eli Lilly and Company)

N/A

Report date: 2025/12/08 17:14:02

Base Information

Drug NameNectin-4 targeting antibody drug conjugate 1 (Eli Lilly and Company)
Drug Alias NameNectin-4 ADC 1
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionNectin-4 modulators
TargetsNectin-4
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesEli Lilly And Company
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A